Physician profile
Arthur C Perry
NPI 1194832725
$1,767.80
in general payments reported to CMS, 2019-2025
14 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $226 · 2020: $188 · 2021: $310 · 2022: $631 · 2023: $122 · 2024: $162 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $411.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $668.86 | 2019-2023 | Tepezza |
| Abbvie INC. | $204.88 | 2022-2025 | |
| Rxsight INC | $143.07 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $140.57 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $125.00 | 2024 | Miebo, Xiidra |
| Sight Sciences, INC. | $101.99 | 2019 | |
| Allergan, INC. | $100.96 | 2019-2022 | |
| Amgen INC. | $79.13 | 2024-2025 | Tepezza |
| Sun Pharmaceutical Industries INC. | $47.77 | 2020-2025 | |
| Kala Pharmaceuticals, INC. | $41.69 | 2019 | |
| Novartis Pharmaceuticals Corporation | $35.66 | 2022 | |
| Alcon Vision LLC | $32.34 | 2025 | Tryptyr |
| Mallinckrodt Hospital Products INC. | $29.91 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $15.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.